Neurocrine Biosciences
Patents, Design & Utilities
Last updated:
List of all Neurocrine Biosciences patents 74 in total
| Status | Patent |
|---|---|
Application | Utility: VALBENAZINE SALTS AND POLYMORPHS THEREOF Filling date: 5 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: Methods for the Administration of Certain VMAT2 Inhibitors Filling date: 5 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: High Dosage Valbenazine Formulation and Compositions, Methods, and Kits Related Thereto Filling date: 5 Sep 2025 Issue date: 3 Sep 2020 |
Application | Utility: Methods for the Administration of Certain VMAT2 Inhibitors Filling date: 5 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: Methods for the Administration of Certain VMAT2 Inhibitors Filling date: 5 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: Methods for the Administration of Certain VMAT2 Inhibitors Filling date: 5 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: Methods for the Administration of Certain VMAT2 Inhibitors Filling date: 5 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: Methods for the Administration of Certain VMAT2 Inhibitors Filling date: 5 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: [9,10-DIMETHOXY-3-(2-METHYLPROPYL)-1H,2H,3H,4H,6H,7H,11BH-PYRIDO-[2,1-A]IS- OQUINOLIN-2-YL]METHANOL AND COMPOUNDS, COMPOSITIONS AND METHODS RELATING THERETO Filling date: 5 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: PROCESSES FOR THE PREPARATION OF URACIL DERIVATIVES Filling date: 5 Sep 2025 Issue date: 13 Aug 2020 |
Grant | Utility: Substituted triazoles and methods relating thereto Filling date: 5 Sep 2025 Issue date: 11 Aug 2020 |
Application | Utility: Methods for the Administration of Certain VMAT2 Inhibitors Filling date: 5 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: Pharmaceutical Compositions Comprising an Antipsychotic Drug and a VMAT2 Inhibitor and Uses Thereof Filling date: 5 Sep 2025 Issue date: 2 Jul 2020 |
Application | Utility: SYNTHETIC METHODS FOR PREPARATION OF (S)-(2R,3R,11bR)-3-ISOBUTYL-9,10-DIMETHOXY-2,3,4,6,7,11b-HEXAHYDRO-1H-PYR- IDO[2,1-a]ISOQUINOLIN-2-YL 2-AMINO-3-METHYLBUTANOATE DI(4-METHYLBENZENESULFONATE) Filling date: 5 Sep 2025 Issue date: 11 Jun 2020 |
Application | Utility: USE OF VALBENAZINE FOR TREATING LEVODOPA-INDUCED DYSKINESIA Filling date: 5 Sep 2025 Issue date: 11 Jun 2020 |
Application | Utility: VMAT2 INHIBITOR COMPOUNDS AND COMPOSITIONS THEREOF Filling date: 5 Sep 2025 Issue date: 30 Apr 2020 |
Application | Utility: TREATMENT OF HYPERKINETIC MOVEMENT DISORDERS Filling date: 5 Sep 2025 Issue date: 2 Apr 2020 |
Application | Utility: GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO Filling date: 5 Sep 2025 Issue date: 26 Mar 2020 |
Application | Utility: Methods for the Administration of Certain VMAT2 Inhibitors Filling date: 5 Sep 2025 Issue date: 26 Mar 2020 |
Application | Utility: Use of Valbenazine for Treating Schizophrenia or Schizoaffective Disorder Filling date: 5 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: Pharmaceutical Compositions Comprising an Antipsychotic Drug and a VMAT2 Inhibitor and Uses Thereof Filling date: 5 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: Methods for the Administration of Certain VMAT2 Inhibitors Filling date: 5 Sep 2025 Issue date: 19 Dec 2019 |
Grant | Utility: Processes for the preparation of uracil derivatives Filling date: 5 Sep 2025 Issue date: 3 Dec 2019 |
Application | Utility: TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA Filling date: 5 Sep 2025 Issue date: 1 Aug 2019 |
Showing 50 to 74 of 74 patents.